Company Analysis

Anika Therapeutics Inc. (ANIK)

Nasdaq: ANIK · Surgical & Medical Instruments & Apparatus · Bedford, MA · filing with the SEC since 1996
Grade5.5
◀ Past 5.7● Present 5.4▶ Future 5.6

Filings

278 filings since 2017 beside 225 insider forms · Accelerated filer · read from EDGAR on Nov 13, 2026
Due nextAccelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Accelerated filers have 75 days after the fiscal year ends. by Mar 16, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 37 days after the quarter ended. The proxy statement was last filed Apr 28, 2026.

Filings a yearinsider forms included
4760495156544542
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 9 times in the last 36 months, the newest Jun 23, 2026.SEC letters: 3 in the last 36 months, the newest Jul 24, 2025.
Insider forms 225

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 6, 2026 10-Q Quarterly report Sep 30, 2026
Nov 6, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 31, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 29, 2026 S-8 Employee stock plan registration
Jul 29, 2026 10-Q Quarterly report Jun 30, 2026
Jul 29, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 17, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 14, 2026 8-K items 1.01, 2.03, 9.01 Major agreement signed; New debt or obligation taken on · Current report Jul 10, 2026
Jun 23, 2026 8-K items 5.02, 5.07, 9.01 Officer or director change; Shareholder vote · Current report Jun 18, 2026
Jun 8, 2026 DEFA14A Extra proxy material
Jun 1, 2026 DEFA14A Extra proxy material
Apr 30, 2026 10-Q Quarterly report Mar 31, 2026
Apr 29, 2026 SCHEDULE 13G Large holder notice
Apr 29, 2026 8-K items 2.02, 5.02, 9.01 Results released; Officer or director change · Current report Apr 24, 2026
Apr 28, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 28, 2026 DEFA14A Extra proxy material
Apr 28, 2026 DEF 14A Proxy statement Jun 18, 2026
Mar 26, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 3, 2026 10-K Annual report Dec 31, 2025
Feb 26, 2026 8-K items 2.02, 5.02, 9.01 Results released; Officer or director change · Current report
Jan 27, 2026 SCHEDULE 13D/A Activist holder update, amended
Jan 8, 2026 8-K items 2.02, 5.02, 9.01 Results released; Officer or director change · Current report Jan 7, 2026
Jan 8, 2026 SCHEDULE 13G/A Large holder update, amended
Nov 21, 2025 SCHEDULE 13D/A Activist holder update, amended
Nov 7, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 5, 2025 S-8 Employee stock plan registration
Nov 5, 2025 10-Q Quarterly report Sep 30, 2025
Nov 5, 2025 8-K items 2.02, 8.01, 9.01 Results released; Other event · Current report
Oct 17, 2025 SCHEDULE 13G Large holder notice
Jul 30, 2025 10-Q Quarterly report Jun 30, 2025
Jul 30, 2025 8-K items 2.02, 9.01 Results released · Current report
Jul 30, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jul 24, 2025 UPLOAD SEC comment letter
Jul 17, 2025 CORRESP Reply to the SEC
Jun 24, 2025 8-K items 5.02, 5.07, 9.01 Officer or director change; Shareholder vote · Current report Jun 20, 2025
Jun 18, 2025 UPLOAD SEC comment letter
May 9, 2025 10-Q Quarterly report Mar 31, 2025
May 9, 2025 8-K items 2.02, 9.01 Results released · Current report
Apr 28, 2025 ARS Annual report to shareholders Dec 31, 2024
Apr 28, 2025 DEFA14A Extra proxy material
40 of 278 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton ANIK · research, not advice